Availability of large-scale evidence on specific harms from systematic reviews of randomized trials

This publication has 17 references indexed in Scilit:

• Synthesising licensing data to assess drug safety
  BMJ, 2004
• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
  JAMA, 2002
• Systematic Reviews Neglect Safety Issues
  Archives of internal medicine (1960), 2001
• Reporting of Adverse Effects in Clinical Trials Should Be Improved
  Journal of Pain and Symptom Management, 1999
• Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens
  The Lancet, 1996
• Japanese and American reports of randomized trials: differences in the reporting of adverse effects
  Controlled Clinical Trials, 1996
• Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis
  Controlled Clinical Trials, 1989
• The case for recording events in clinical trials.
  BMJ, 1977
• The Discovery of Drug-Induced Illness
  New England Journal of Medicine, 1977